AN2 Therapeutics (ANTX) has had the highest return since January 1, 2026 by a US stock with an IPO date in 2022, returning 346.4%.
| ASSET | % RETURN |
|---|---|
AN2 Therapeutics (ANTX) | 346.43% |
Envirotech Vehicles (EVTV) | 316.67% |
Westrock Coffee (WEST) | 117.07% |
RXO (RXO) | 99.92% |
Amprius Technologies (AMPX) | 91.36% |
Credo Technology (CRDO) | 83.17% |
Ryvyl (RVYL) | 83.04% |
Definium Therapeutics (DFTX) | 81.33% |
Nuvectis Pharma (NVCT) | 79.95% |
Akanda (AKAN) | 79.17% |
M-tron Industries (MPTI) | 78.66% |
JE Cleantech (JCSE) | 72.73% |
United Maritime (USEA) | 63.95% |
Himalaya Shipping (HSHP) | 62.9% |
V2X (VVX) | 55.4% |
ProFrac (ACDC) | 55.24% |
Anghami (ANGH) | 55.04% |
John Wiley & Sons (WLY) | 53.43% |
John Wiley & Sons B (WLYB) | 46.88% |
Gorilla Technology (GRRR) | 44.08% |
Gogoro (GGR) | 42.86% |
Aeluma (ALMU) | 39.91% |
Locafy (LCFY) | 38.73% |
EON Resources (EONR) | 37% |
Zhong Yang Financial Group Limited Ordinary Shares (TOP) | 35.64% |